New weight-loss drugs like Ozempic and Wegovy are sparking a quiet revolution, with economists predicting they could add hundreds of billions to the U.S. GDP by slashing healthcare costs, boosting productivity, and transforming daily life. As real-world use grows, the ripple effects—from personal health transformations to broader economic shifts—are becoming undeniable, raising urgent questions about cost and access while reshaping how we view public health and economic growth.
Listen in comfort: Get a discount on a Soli Pillow: http://solipillow.com/discount/dnn.
Advertise on DNN: advertise@thednn.ai
This is an automated, high-level news summary based on public reporting. Report issues to feedback@thednn.ai.
Podden och tillhörande omslagsbild på den här sidan tillhör
The Daily News Now!. Innehållet i podden är skapat av The Daily News Now! och inte av,
eller tillsammans med, Poddtoppen.
